Putting patients first by introducing supply chain visibility and efficiency to Investigator Initiated Trials
Investigator Initiated Trials (IITs) play an important role in helping sponsor companies better understand their drugs. Such studies support the discovery of new applications for existing therapeutics that contribute to enhanced treatment options and promote better health outcomes for patients. However, managing these studies presents unique and complex clinical supply chain challenges.
In this case, one biotechnology company was supplying over twenty individual IIT programs with its drug. The IIT programs were geographically dispersed, single-site operations, and each with a specific protocol to adhere to.
Download the Case study to find out how Almac Clinical Services helped this sponsor effectively manage drug supply for multiple IIT programs.
View Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.
